SFX by Ex Libris Inc.

Title:	Simultaneous Formation and Micronization of Pharmaceutical Cocrystals by Rapid Expansion of Supercritical Solutions (RESS)
Source:	Pharmaceutical Research [0724-8741] Müllers, Katrin yr:2014

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Rodriguez-Hornedo, N. "Solubility Advantage of Pharmaceutical Cocrystals." Crystal growth & design 9.5 (2009): 2252-2264.
description	2.	Savjani, Jignasa K. "Co-crystallization: An approach to improve the performance characteristics of active pharmaceutical ingredients." Asian journal of pharmaceutics 9.3 (2015): 147-151.
description	3.	Esmaeilzadeh, F. "Crystallization of micro particles of sulindac using rapid expansion of supercritical solution." Journal of Crystal Growth 312.22 (2010): 3373-3383.
description	4.	Padrela, L. "Formation of indomethacin-saccharin cocrystals using supercritical fluid technology." European journal of pharmaceutical sciences 38.1 (2009): 9-17.
description	5.	Herrmann, M. "Co-Crystallization and Characterization of Pharmaceutical Ingredients." Particle & particle systems characterization 26.3 (2009): 151-156.
description	6.	Remenar, Julius F. "Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids." Journal of the American Chemical Society 125.28 (2003): 8456-8457.
description	7.	Weyna, D. "Synthesis and Structural Characterization of Cocrystals and Pharmaceutical Cocrystals: Mechanochemistry vs Slow Evaporation A from Solution." Crystal growth & design 9.2 (2009): 1106-1123.
description	8.	Friščić, T. "The role of solvent in mechanochemical and sonochemical cocrystal formation: a solubility-based approach for predicting cocrystallisation outcome." CrystEngComm 11.3 (2009): 418-426.
description	9.	Newman, N. "Pharmaceutical Cocrystals and Their Physicochemical Properties." Crystal growth & design 9.6 (2009): 2950-2967.
description	10.	Blagden, N. "Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates." Advanced Drug Delivery Reviews 59.7 (2007): 617-630.
description	11.	Guzman, H. "Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations." Journal of pharmaceutical sciences 96.10 (2007): 2686-2702.
description	12.	Reverchon, E. "Spherical microparticles production by supercritical antisolvent precipitation: Interpretation of results." The Journal of supercritical fluids 47.1 (2008): 70-84.
description	13.	Desiraju, Gautam R R. "Hydrogen bridges in crystal engineering: interactions without borders." Accounts of chemical research 35.7 (2002): 565-73.
description	14.	Nugrahani, Y. "Study of physical interaction mefenamic acid ? isonicotinamide." Aip Conference Proceedings 1677 (2015): 100010-.
description	15.	Reverchon, E. "Supercritical fluids based techniques to process pharmaceutical products difficult to micronize: Palmitoylethanolamide." The Journal of supercritical fluids 102 (2015): 24-31.
description	16.	Chen, F. "Preparation and Characterization of Tripterygium wilfordii Multi-Glycoside Nanoparticle Using Supercritical Anti-Solvent Process." International journal of molecular sciences 15.2 (2014): 2695-2711.
description	17.	Abd Rahim, S. "A comparative assessment of the influence of different crystallization screening methodologies on the solid forms of carbamazepine co-crystals." CrystEngComm 15.19 (2013): 3862-3873.
description	18.	Uekama, K. "Novel Approach of Cyclodextrin-based Pharmaceutical Formulation." 薬学雑誌 132.1 (2012): 85-105.
description	19.	Vemavarapu, C. "Coprecipitation of pharmaceutical actives and their structurally related additives by the RESS process." Powder technology 189.3 (2009): 444-453.
description	20.	Maehashi, K., Matano, M., Nonaka, M., Udaka, S., Y, K. "Riboflavin-Binding Protein Is a Novel Bitter Inhibitor." Chemical Senses 33.1 (2008): 57-63.